[EN] TRIAZOLOPYRIDINE ETHER DERIVATIVES AND THEIR USE IN NEUROLOGICAL AND PYSCHIATRIC DISORDERS<br/>[FR] DÉRIVÉS D'ÉTHER DE TRIAZOLOPYRIDINE ET LEUR UTILISATION CONTRE DES TROUBLES NEUROLOGIQUES ET PYSCHIATRIQUES
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2015042243A1
公开(公告)日:2015-03-26
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds modulate the mGluR2 receptor and may be useful for the treatment of various disorders of the central nervous system.
该披露通常涉及到I式化合物,包括它们的盐,以及使用这些化合物的组合物和方法。这些化合物调节mGluR2受体,可能有助于治疗中枢神经系统的各种疾病。